Product Type: Inhibitor
CAS No.: 608512-97-6
MolecularFormula: C13H8N4OS
Molecular Weight: 268,3
Source: Synthetic
Purity: ≥98% (HPLC)
Solubility: Soluble in DMSO 12 mg/ml
Appearance: Solid
PubChem CID: 67016828
Scientific Background: C16 is a derivative of imidazolo-oxindole and inhibits RNA-dependent protein kinases (PKR). Its inhibition effect on PKR is ATP-binding site directed. C16 has been shown to specifically inhibit the apoptotic PKR/eIF2a signaling pathway.
References: 1. Couturier J., et al. (2010) J. Biol. Chem. 285(2): 1272–1282. 2. Jammi N.V., Whitby L.R., & Beal P.A. (2003) Biochem. Biophys.Res. Comm. 308(1):50–57.
Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.